Sanai Health Industry Group Company Limited

Research Sanai Health Industry Group Company Limited (WUP0) on Bullrun: market cap EUR 2.75M, P/E 1.8. Explore financials, valuation history, model signals, and stock context.

Key Metrics

Valuation Snapshot

latest market cap is EUR 2.75M; P/E is 1.8.

Peer valuation comparison

Latest P/E is 1.8x versus a Healthcare sector median of 24.46x (92.6% below).

Latest P/E is 1.8x versus a Hong Kong median of 10.75x (83.3% below).

Five-year financial history

YearRevenueNet incomeFree cash flowGross marginDiluted EPSCashTotal debtEquity
FY2025CNY 85.90M-CNY 22.04M-CNY 54.36M16.7%-0.14CNY 298.60MCNY 44.04MCNY 298.26M
FY2024CNY 85.22MCNY 4.89MCNY 10.63M19.8%0.03CNY 340.43MCNY 41.93MCNY 321.99M
FY2023CNY 107.77MCNY 18.63MCNY 320.61M27.1%0.13CNY 332.47MCNY 62.48MCNY 264.45M
FY2022CNY 175.92MCNY 29.22M-CNY 56.22M52.1%0.22CNY 21.84MCNY 71.07MCNY 245.59M
FY2021CNY 67.61MCNY 9.03M-CNY 38.81M60.0%0.07CNY 16.30MCNY 0CNY 199.07M

Valuation history

YearSnapshot dateMarket capP/EDividend yieldAnnual dividend/share
20262026-08-29EUR 2.75M1.8n/a0

Dividend history

Latest trailing dividend snapshot: annual dividend/share 0 EUR.

About Sanai Health Industry Group Company Limited

Sanai Health Industry Group Company Limited, an investment holding company, engages in the manufacture, marketing, and sale of branded prescription and non-prescription drugs, and Chinese pharmaceutical products in the People's Republic of China and Hong Kong. It operates through Pharmaceutical Products and Finance Leasing segments. The company is involved in development, manufacturing, marketing, and sales of pharmaceutical products; sale of pharmaceutical related software; and provision of consultancy services.

Related stock research

Other Healthcare stocks

Frequently asked questions

What is Sanai Health Industry Group Company Limited's market cap?

Sanai Health Industry Group Company Limited's market capitalization is EUR 2.75M.

What is Sanai Health Industry Group Company Limited's P/E ratio?

Sanai Health Industry Group Company Limited's price-to-earnings (P/E) ratio is 1.8.

What does Sanai Health Industry Group Company Limited do?

Sanai Health Industry Group Company Limited, an investment holding company, engages in the manufacture, marketing, and sale of branded prescription and non-prescription drugs, and Chinese pharmaceutical products in the People's Republic of China and Hong Kong. It operates through Pharmaceutical Products and Finance Leasing segments. The company is involved in development, manufacturing, marketing, and sales of pharmaceutical products; sale of pharmaceutical related software; and provision of consultancy services.